We are live on ! Find out more
BIVI icon

BioVie

39 hedge funds and large institutions have $9.5M invested in BioVie in 2022 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 11 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,000% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 1

694% more capital invested

Capital invested by funds: $1.2M → $9.5M (+$8.3M)

525% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 4

117% more funds holding

Funds holding: 1839 (+21)

0.02% more ownership

Funds ownership: 0.02%0.04% (+0.02%)

Holders
39
Holders Change
+21
Holders Change %
+116.67%
% of All Funds
0.63%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
25
Increased
11
Reduced
1
Closed
4
Calls
Puts
Net Calls
Net Calls Change

BIVI Hedge Fund Activity: Q4 2022 in Review

39 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in BioVie (BIVI) for Q4 2022, worth a combined $9.5M — up 694% from $1.2M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new BIVI positions and 4 closed out — a net gain of 21 holders — while 11 added to existing stakes and 1 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $1.48M. The largest seller was Sabby Management, exiting entirely with an estimated $244K sold.

  • 39 institutional investors held BioVie (BIVI) as of Q4 2022, up from 18 in Q3 2022.
  • Funds reported $9.5M of BioVie stock for Q4 2022, up 694% quarter-over-quarter.
  • 25 funds opened new BioVie positions in Q4 2022 and 4 closed out, a net change of +21 holders.
  • The largest BioVie buyer in Q4 2022 was Renaissance Technologies, an estimated $1.48M added.
  • The largest BioVie seller in Q4 2022 was Sabby Management, an estimated $244K sold.

Based on aggregated 13F filings for Q4 2022.